Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/20/2003US20030055017 Gene therapy
03/20/2003US20030055013 Administering ribavirin for a time sufficient to lower viral-RNA in association with a therapeutically effective amount of an antioxidant therapy comprising S-adenosyl methionine to ameliorate ribavirin-related hemolysis
03/20/2003US20030055006 Combinations and compositions which interfere with VEGF/VEGF and angiopoietin/tie receptor function and their use
03/20/2003US20030055005 Gamma-secretase inhibitors
03/20/2003US20030055004 GPE analogs and peptidominetics
03/20/2003US20030055003 Administering copper chelator and activated protein C (APC) or protein C or agent that increases the synthesis of protein C in the animal, or both, an activator of protein C for therapy
03/20/2003US20030055002 For cancer therapy
03/20/2003US20030055001 Immune-enhancing peptides
03/20/2003US20030055000 Non-natural galanin receptor ligands
03/20/2003US20030054999 Anti-inflammatory compounds and uses thereof
03/20/2003US20030054998 Prolactin induced increase in neural stem cell numbers
03/20/2003US20030054997 OB protein compositions and methods
03/20/2003US20030054996 Contacting complex comprising a GRP94 protein with a binding agent that is immobilized to a solid phase support, to immobilize the complex to solid phase support; collecting the remaining sample; eluting the complex from solid phase support
03/20/2003US20030054995 Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic disease or stroke
03/20/2003US20030054991 Inhibitors of glycosaminoglycans
03/20/2003US20030054990 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
03/20/2003US20030054989 For diagnosis, treatment, and/or prevention of various diseases and/or disorders
03/20/2003US20030054987 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054986 Novel DNA and to the recombinant production of novel polypeptides encoded by that DNA
03/20/2003US20030054984 Treating obesity and non-insulin-dependent (type II) diabetes mellitus (NIDDM) by specifically targeting the genes and gene products of cathepsins
03/20/2003US20030054983 Antibiotics AA-896
03/20/2003US20030054982 Tumors, and metastasis
03/20/2003US20030054981 Parenteral formulation of an echinocandin compound, the micelle-forming surfactant, and a nontoxic, aqueous solvent, in given weight ratio of surfactant to echinocandin; treating fungal infections
03/20/2003US20030054980 Ceruloplasmin and uses thereof in neurodegenerative related conditions
03/20/2003US20030054976 Such as gonadotrophin releasing hormone, or dermorphin; use treating syndromes and disorders associated with unwanted oxidative processes in the extracellular space, including arthritis, cataracts, diabetes and artherosclerosis
03/20/2003US20030054975 By administering a Clostridial toxin to a peripheral location on the body of a patient
03/20/2003US20030054973 Methods and compositions for the repair and/or regeneration of damaged myocardium
03/20/2003US20030054554 Albumin derivatives with therapeutic functions
03/20/2003US20030054551 Amplification of neuronal stem cells; prepare nutrient broth, mix with modulator, inoculate with stem cells monitor propagation activity in cells
03/20/2003US20030054550 Cardiac hypertrophy factor and uses therefor
03/20/2003US20030054532 Reduction in aggregation of enzymes in liquid solutions; obtain sample containing enzymatic polypeptide, incubate with modulator, monitor adjustment in aggregation activity
03/20/2003US20030054530 Esterases
03/20/2003US20030054528 Mitogen-activated protein kinase p38-2 and methods of use therefor
03/20/2003US20030054527 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of thrombocytopenia
03/20/2003US20030054526 Transglutaminase ztg2
03/20/2003US20030054525 UDP-N-acetylglucosamine: galactose-beta1,3-N-acetylgalactosamine-alpha-R / (GlcNAc to GalNAc) beta1,6-N-acetylglucosaminyltransferase, C2GnT3
03/20/2003US20030054517 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054516 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054514 Novel polynucleotides and proteins encoded thereby
03/20/2003US20030054508 Substantially pure glycopeptide antibotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 AND AC-98-5
03/20/2003US20030054494 Novel chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
03/20/2003US20030054493 Identification of neutralizing epitopes of toxin A and toxin B for the treatment of C. difficile disease
03/20/2003US20030054492 Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
03/20/2003US20030054490 Isolated human phosphatase proteins, nucleic acid molecules encoding phosphatase proteins and uses thereof
03/20/2003US20030054489 Peptide for use in the treatment of inflammation, cancer and arteriosclerosis
03/20/2003US20030054488 Goodpasture antigen binding protein
03/20/2003US20030054453 68723, sodium/glucose cotransporter family members and uses therefor
03/20/2003US20030054452 Lysolipid for use in controlling apoptosis and treating inflammatory and innumological disorders
03/20/2003US20030054446 Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379
03/20/2003US20030054445 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01
03/20/2003US20030054444 Nucleotide sequences coding polypeptide for use in the treatment of aberrant cell propagation and nervous system disorders
03/20/2003US20030054441 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054440 Novel proteins with integrin-like activity
03/20/2003US20030054439 Truncated soluble tumor necrosis factor type-I and type-II receptors
03/20/2003US20030054438 Polypeptide for use in the diagnosis and treatment of cancer
03/20/2003US20030054437 Modulating growth, differentiation, or survival of cells; obtain cells, incubate with modulator, monitor adjustments in cell activity
03/20/2003US20030054421 Nucleotide sequences coding polypeptide for use in the treatment of cancer
03/20/2003US20030054420 Nucleic acids, proteins, and antibodies
03/20/2003US20030054417 Epithelial protein lost in neoplasm (EPLIN)
03/20/2003US20030054409 Novel complex-forming proteins
03/20/2003US20030054406 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054405 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054404 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054403 Nucleotide sequences coding membrane protein for use in the treatment, diagnosis and prevention of cancer, nervous system, viral, kidney and inflammatory diseases
03/20/2003US20030054401 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054400 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054398 Isolated human aminotransferase proteins, nucleic acid molecules encoding aminotransferase proteins and uses thereof
03/20/2003US20030054385 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention tumor, immunological and nervous system disorders
03/20/2003US20030054375 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of connective tissue and cancer disorders
03/20/2003US20030054374 Nucletide sequences coding membrane protein for use ikn the treatment, diagnosis and prevention of cancer, kidney, connective tissue, reproductive and lung disorders
03/20/2003US20030054373 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer
03/20/2003US20030054365 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression
03/20/2003US20030054363 Compositions and methods for the therapy and diagnosis of lung cancer
03/20/2003US20030054359 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer and nervous system disorders
03/20/2003US20030054352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054351 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054349 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054345 Compositions and methods for the diagnosis and treatment of neuropsychiatric disorders, including schizophrenia
03/20/2003US20030054341 Viral nucleotide sequences for use in diagnosis, prevention and treatment of viral diseases
03/20/2003US20030054034 Water soluble film forming polymer and microbiocide oil
03/20/2003US20030054028 Sustained releasing drug in situ
03/20/2003US20030054018 Single-dose administration of factor VIIa
03/20/2003US20030054011 Anticancer agents
03/20/2003US20030054010 Molecular antigen array
03/20/2003US20030054008 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
03/20/2003US20030054007 Intracellular protein delivery compositions and methods of use
03/20/2003US20030054005 Using monoclonal antibodies; polymerase chain reactions
03/20/2003US20030054004 In situ diagnosis, therapy; antitumor agent; administering dosage of tumornecrosis factor antibody
03/20/2003US20030054001 Antibody, antigen complex
03/20/2003US20030054000 Anti-pathogen system and methods of use thereof
03/20/2003US20030053998 Methods and active substances for protecting organs
03/20/2003US20030053994 Genetic engineering; desroying infections; antitumor, anticancer agents
03/20/2003US20030053993 Regeneration of nerve cells
03/20/2003US20030053991 Retinoic acid receptor beta-2, its agonists, and gene theraphy vectors for the treatment of neurological disorders
03/20/2003US20030053990 Virus vectors and methods of making and administering the same
03/20/2003US20030053989 Administering nucleic acid
03/20/2003US20030053987 Synthetic hepatitis c genes
03/20/2003US20030053986 Method of treating hepatitis C infection
03/20/2003US20030053985 Method and pharmaceutical composition for treating inflammation
03/20/2003US20030053984 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
1 ... 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 ... 3163